Novel role of the #ExtracellularMatrix as a mediator of signaling between growth factors and estrogen receptor-positive #BreastCancer, reported by DiGiacomo et al @INBT_JHU. https://t.co/U3TCNInrHv https://t.co/dAoHnrykHY

RT @MCR_AACR: Novel role of the #ExtracellularMatrix as a mediator of signaling between growth factors and estrogen receptor-positive #Brea…

Novel role of the #ExtracellularMatrix as a mediator of signaling between growth factors and estrogen receptor-positive #BreastCancer, reported by DiGiacomo et al. @INBT_JHU https://t.co/BcgQt2Lpag https://t.co/7VYnWG9ADn

Novel role of the #ExtracellularMatrix as a mediator of signaling between growth factors and estrogen receptor-positive #BreastCancer reported by DiGiacomo et al. @INBT_JHU https://t.co/H9dwtWsWQn https://t.co/WWmRtWSOMO

Catching up on reading today. 2 things that don't get enough press on my feed imo: 1) using ECM from non-epi tumor cells in 3D culture; 2) the concept of E2-independent #estrogenreceptor activation in endo-resistant #breastcancer. Must remedy. https://t.c

Novel role of the #ExtracellularMatrix as a mediator of signaling between growth factors and estrogen receptor-positive #BreastCancer reported by DiGiacomo et al. @INBT_JHU https://t.co/rm0ysXbit6 https://t.co/O9S27TO5ng

RT @MammaryCell: 👨‍🔬👩‍🔬Dr. Daniele Gilkes's lab (@GilkesLab) at @JohnsHopkins suggests that ER+ #BreastCancer patients that have high mammo…

👨‍🔬👩‍🔬Dr. Daniele Gilkes's lab (@GilkesLab) at @JohnsHopkins suggests that ER+ #BreastCancer patients that have high mammographic breast density and an intact FGFR signaling pathway may benefit from existing FGFR-targeted therapies. @MCR_AACR: https://t.c